Ontrak Health and Optima Health Sign New Amendment to Impact Highest Acuity Members
Ontrak, Inc. (NASDAQ: OTRK) has signed an amendment with Optima Health to enhance its Wholehealth+ care program targeting high-acuity, cost-prohibitive members in their commercial line. This agreement leverages Ontrak’s AI-enabled Advanced Engagement System for real-time feedback and improved health outcomes. Expected to launch in January 2023, the amendment could boost Ontrak's outreach by 10-15%. Both organizations emphasize member health improvements as central to the partnership.
- Amendment with Optima Health focuses on high-acuity members, enhancing care delivery.
- 10-15% increase in outreach pool expected upon launch in January 2023.
- None.
This updated agreement allows
“We are grateful for the continued partnership and support of
Dr.
The amendment will represent an estimated 10
About
Learn more at www.ontrakhealth.com.
Cautionary Note Regarding Forward looking statements
Except for statements of historical fact, the statements made in this presentation are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “could,” “should,” “believes,” “estimates,” “projects,” “potential,” “expects,” “plan,” “anticipates,” “intends,” “continues,” “forecast,” “designed,” “goal,” or the negative of those terms and other similar expressions. Such statements include, but are not limited to, statements relating to: expectations regarding future revenue from existing health plan customers, including but not limited to expected effective outreach pool of our existing customers; budget considerations and timing of expansions; and acceleration and adoption of our AI-enhanced clinical and operating model. Forward-looking statements reflect management’s estimates and expectations based on current information and involve assumptions and risks and uncertainties, many of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others: the impact of changes in management and organizational structure; the impact of cost cutting initiatives under our restructuring plan on our ability to retain, serve and grow our customer base; risks associated with our ability to retain key personnel, including members of our board of directors, and the ability to recruit, retain and develop a large and diverse workforce; risks associated with our high customer concentration and the ability of a customer to terminate a contract with us for convenience; intense competition and substantial regulation in the health care industry; changes in regulations or issuance of new regulations or interpretations; our limited operating history; our ability to execute our business plan; our ability to increase our revenue and achieve profitability; the risk of lower than anticipated effective outreach under our contracts; our inability to recognize revenue; the adequacy of our existing cash resources and our ability to continue as a going concern; our ability to satisfy the conditions precedent to funding under the Keep Well Agreement we entered with an affiliate of our Chairman and Chief Executive Officer and to satisfy ongoing covenants associated with such arrangement; our ability to raise additional capital when needed, and the dilutive impact of potential equity capital raises; risks associated with the lack of outcomes and statistically significant formal research studies; risks associated with difficulty enrolling new members and maintaining existing members in our programs; the risk that the treatment programs might not be effective; risks associated with difficulty in developing, exploiting and protecting proprietary technologies; business disruption and related risks resulting from the ongoing pandemic; risks related to our ability to realize the potential benefits of and to effectively integrate acquisitions; our ability to continue to remain listed on a tier of the
View source version on businesswire.com: https://www.businesswire.com/news/home/20230109005237/en/
Investors:
investors@ontrakhealth.com
Media Contact:
Chief Marketing Officer
646-510-0893
jprieto@ontrakhealth.com
Source:
FAQ
What is the purpose of the amendment between Ontrak and Optima Health?
When will the new agreement between Ontrak and Optima Health be launched?
How much will Ontrak's outreach increase due to the new amendment?